Number of items: 11.
2020
Horne, G. et al.
(2020)
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease.
Leukemia, 34(7),
pp. 1775-1786.
(doi: 10.1038/s41375-019-0700-9)
(PMID:31925317)
(PMCID:PMC7224085)
2018
Ashton, M. et al.
(2018)
SYSTEMS-2: a randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.
Clinical and Translational Radiation Oncology, 8,
pp. 45-49.
(doi: 10.1016/j.ctro.2017.11.004)
Fulton, B. et al.
(2018)
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status.
Clinical and Translational Radiation Oncology, 8,
pp. 12-16.
(doi: 10.1016/j.ctro.2017.11.003)
2017
Paul, J. , Kelly, C. , Stobo, J. and Powles, T.
(2017)
Reply to M. Horiguchi et al.
Journal of Clinical Oncology, 35(29),
pp. 3373-3374.
(doi: 10.1200/jco.2017.74.4292)
(PMID:28800270)
Jones, R. J. et al.
(2017)
Randomized phase II study investigating pazopanib versus weekly paclitaxel in relapsed or progressive urothelial cancer.
Journal of Clinical Oncology, 35(16),
pp. 1770-1777.
(doi: 10.1200/JCO.2016.70.7828)
(PMID:28402747)
Goranova, T. et al.
(2017)
Safety and utility of image-guided research
biopsies in relapsed high-grade serous
ovarian carcinoma—experience of the
BriTROC consortium.
British Journal of Cancer, 116,
pp. 1294-1301.
(doi: 10.1038/bjc.2017.86)
(PMID:28359078)
(PMCID:PMC5482731)
2016
MacLeod, N., Kelly, C. , Stobo, J. , McMahon, L., Taggart, D., Fallon, M. and Laird, B. J.
(2016)
Pain in malignant pleural mesothelioma: a prospective characterization study.
Pain Medicine, 17(11),
pp. 2119-2126.
(doi: 10.1093/pm/pnw061)
(PMID:27117437)
2015
Mac Leod, N. et al.
(2015)
F-18 FDG PET-CT influences target delineation when combined with standard CT-based radiotherapy planning in the palliative setting in malignant pleural mesothelioma; an exploratory study.
Reports of Radiotherapy and Oncology, 2(2),
e3999.
(doi: 10.17795/rro-3999)
MacLeod, N. et al.
(2015)
Is radiotherapy useful for treating pain in mesothelioma?: a phase II trial.
Journal of Thoracic Oncology, 10(6),
pp. 944-950.
(doi: 10.1097/JTO.0000000000000499)
(PMID:25654216)
2013
Gallipoli, P. et al.
(2013)
Safety and efficacy of pulsed imatinib with or without G-CSFversuscontinuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up.
British Journal of Haematology, 163(5),
pp. 674-676.
(doi: 10.1111/bjh.12532)
Chen, M. et al.
(2013)
Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex.
Journal of the National Cancer Institute, 105(6),
pp. 405-423.
(doi: 10.1093/jnci/djt006)
(PMID:23446755)
(PMCID:PMC3601953)
This list was generated on Mon Feb 6 07:08:54 2023 GMT.